Er is een fout opgetreden!
Epigenomics Aandeel
| 1,23EUR | 0,07EUR | 5,58% |
Epigenomics Grafiek - 1 Jaar - L&S
Nieuws voor Epigenomics AG
| Geen nieuws beschikbaar |
Analisten over Epigenomics AG
Epigenomics Peer Group
| Epigenomics | 1,23 | 5,6% |
Wat denkt u?
Profiel Epigenomics AGnaar bedrijfsprofiel
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma (HCC) The comapny was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo Gut on April 30, 1997 and is headquartered in Berlin, Germany.
Realtime koers Epigenomics AG
| Bid |
1,20
EUR
|
Ask |
1,25
EUR
|
|---|---|---|---|
| Tijd |
17:23
|
Beurs | CHX |
Aandelenkoers Epigenomics AG in EURPush activeren
| Koers | 1,23 EUR | 0,07 | 5,58 % |
| Tijd | 17:46:17 |
| Handelsdatum | 19.11.2019 |
| Opening | 1,09 |
| Slot | 1,17 |
| Hoogste | 1,29 |
| Laagste | 1,07 |
| 52 W. Hoog | 2,25 |
| 52 W. Laag | 0,856 |
| 52 W. Perf. | |
| Volume (Aantal) | 42.317 |
| Marktkap. (EUR) | 46,72 Mln |
| Beurs |
Naar aandeel Epigenomics
| ISIN | DE000A11QW50 |
| Indices | Prime All Share, CDAX |
Epigenomics Kerncijfers
| Marktkapitalisatie in Euro | 46,72 Mln |
| Vrij verhandelbaar in % | |
| Aantal Aandelen | 41,53 |
| Kasstroom/Aandeel in lokale valuta | |
| Boekwaarde/Aandeel in lokale valuta | |
| 60 Dagen Volatiliteit | 71,22 |
| K/B verhouding |
Epigenomics Historische koersen
| 18-11-2019 | 1,17 | 2.050 | |
| 17-11-2019 | 1,16 | 4.600 | |
| 16-11-2019 | 1,12 | ||
| 15-11-2019 | 1,14 | 6.980 | |
| 14-11-2019 | 1,07 | 14.201 |